Echocardiographic assessment for Cardiac Resynchronization Therapy
echocardiographic assessment for Cardiac Resynchronization Therapy (CRT), aligned with ACC/AHA/ESC practice, echo lab workflow, and...
Pericarditis – One-Liner Case Traps
Pericarditis – One-Liner Case Traps Pericarditis – 50 Ultra-Hard FAQs (NEET-SS) 1. Why does PR...
Pericarditis – Core Concepts
Pericarditis – Core Concepts Definition Inflammation of the pericardial sac, which may be acute, incessant,...
Diagnosis and management of stress cardiomyopathy (Takotsubo syndrome)
Diagnosis and management of stress cardiomyopathy (Takotsubo syndrome) TRESS (TAKOTSUBO) CARDIOMYOPATHY – 100 FAQs WITH...
Diagnosis and management of stresscardiomyopathy
STRESS CARDIOMYOPATHY (TAKOTSUBO SYNDROME) Definition A transient, reversible acute heart failure syndrome characterized by regional...
Imaging of Vulnerable Plaque-FAQs
Imaging of Vulnerable Plaque — 60 FAQs (5 Points Each) 1. What is a vulnerable...
Imaging of Vulnerable Plaque — Current Status
Imaging of Vulnerable Plaque — Current Status 1. What Is a “Vulnerable Plaque” (Concept Update)...
Class I Indications for Coronary Angiography
Class I Indications for Coronary Angiography 1. Acute Coronary Syndromes 2. Stable Ischemic Heart Disease...
Current Status of Drug-Eluting Stents in Coronary Heart Disease
1. Fundamental Role of DES in CHD Management Percutaneous coronary intervention (PCI) with stent implantation...
Ion channelopathies in the genesis of cardiac arrhythmias
1. Definition and Scope Ion channelopathies are disorders caused by dysfunction of cardiac ion channels...
β blockers for aortic regurgitation
β blockers for aortic regurgitation β-Blockers in Aortic Regurgitation (AR) Bottom line:β-blockers are generally avoided…
Erythropoietin (ESA) Resistance — 50 FAQs
Erythropoietin (ESA) Resistance — 50 FAQs What is ESA resistance?Failure to achieve or maintain target…
Erythropoietin (EPO) Resistance
Erythropoietin (EPO) Resistance DefinitionErythropoietin resistance—also termed hyporesponsiveness to erythropoiesis-stimulating agents (ESAs)—is the failure to achieve…
Heart Failure with Preserved Ejection Fraction (HFpEF)- Short Questions-FAQs
Heart Failure with Preserved Ejection Fraction (HFpEF)- Short Questions-FAQs 1. What defines HFpEF? Heart failure…
Heart Failure with Preserved Ejection Fraction (HFpEF)
Heart Failure with Preserved Ejection Fraction (HFpEF) Definition HFpEF is a clinical syndrome of heart…
IVUS – LM & Bifurcation MCQs – What we should know
IVUS — Ultra–High-Difficulty MCQs (LM & Bifurcation, Trial‑Heavy) IVUS in Left Main & Bifurcation PCI…
Intravascular Ultrasound (IVUS) in Coronary Artery Disease
Intravascular Ultrasound (IVUS) in Coronary Artery Disease IVUS in Coronary Artery Disease — 40 SS-Level…
Anticoagulation in pregnancy
Anticoagulation in Pregnancy — 50 Advanced FAQs (SS / DM Level) Each FAQ is answered…
Embolic Protection Devices (EPDs) and Thrombectomy Devices
Embolic Protection Devices (EPDs) and Thrombectomy Devices, emphasizing mechanisms, indications, landmark trials, guideline positions, and…
ATRIAL FIBRILLATION (40 ADVANCED FAQs)
SS / DM CARDIOLOGY — ATRIAL FIBRILLATION (40 ADVANCED FAQs) 1. Why did EAST-AFNET 4…
Diagnosis and Management of Atrial Fibrillation
Diagnosis and Management of Atrial Fibrillation (AF), aligned with ESC / ACC-AHA principles and suitable…
Molecular Basis of Coronary Artery Disease — High‑Yield MCQs
Molecular Basis of Coronary Artery Disease — 40 High‑Yield MCQs Final‑week Rapid Revision — Molecular…
Lipid-Lowering Drug Guidelines MCQs
Lipid-Lowering Drug Guidelines-MCQs
Lipid-Lowering Drug Guidelines — 60 MCQs (Part 1 of 3) Lipid-Lowering Drug Guidelines — 60…
Lipid-Lowering Drug Guidelines – Clinical Summary
Lipid-Lowering Drug Guidelines (ACC/AHA + ESC/EAS — Consolidated Clinical Summary) 1. Primary Targets GuidelinePrimary TargetSecondary…
